Besides, alterations in the glutamatergic system like deficiencies in synaptic NR2B subunit phosphorylation and an accumulation and over-stabilization of mGlu5 are also considered as factors promoting the development of AD and might have been changed in our animals [64–66]. Here, GRM5 is linked to Alzheimer disease.